| 1001 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 106) | GCST90320925 | 4.53 |
| 1002 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T34 | ECGA000034 | 4.52 |
| 1003 | LAMA4/NID1 ratio | GCST90315272 | 4.52 |
| 1004 | LDLR levels | GCST90179346 | 4.52 |
| 1005 | IGFBP4/OGN ratio | GCST90315134 | 4.52 |
| 1006 | C1QL2 levels | GCST90468487 | 4.51 |
| 1007 | XRCC4 levels | GCST90471085 | 4.51 |
| 1008 | Hemorrhoids | circulatory system | UKBB00000325 | 4.51 |
| 1009 | Operation code - coronary angioplasty (ptca) +/- stent | Operations | UKBB00000555 | 4.50 |
| 1010 | IDP dMRI ProbtrackX OD str r | GCST90004474 | 4.50 |
| 1011 | COL6A3 levels | GCST90468821 | 4.50 |
| 1012 | ANGPT2 levels | GCST90468301 | 4.49 |
| 1013 | Diarrhoea and gastroenteritis of presumed infectious origin | FING00000420 | 4.49 |
| 1014 | Triglyceride to HDL cholesterol ratio | GCST90295951 | 4.48 |
| 1015 | DPP6/SEZ6L ratio | GCST90314544 | 4.48 |
| 1016 | FEV1/FVC ratio | Other measurement | UKBB00000245 | 4.48 |
| 1017 | IDP dMRI ProbtrackX L3 fmi | GCST90004311 | 4.47 |
| 1018 | Diastolic blood pressure, combined automated + manual reading | Cardiovascular measurement | UKBB00000176 | 4.47 |
| 1019 | rfMRI connectivity (ICA100 edge 399) | GCST90005252 | 4.47 |
| 1020 | wg lh intensity-contrast parsorbitalis | GCST90003810 | 4.46 |
| 1021 | BA-exvivo lh volume BA3b | GCST90002838 | 4.46 |
| 1022 | Diastolic blood pressure, combined automated + manual reading | Cardiovascular measurement | UKBB00000177 | 4.46 |
| 1023 | IDP T1 FAST ROIs L cerebellum VIIIb | GCST90002581 | 4.46 |
| 1024 | Benign mammary dysplasia | FING00000151 | 4.46 |
| 1025 | Comorbidity of gastric and duodenal ulcers | GCST90270929 | 4.45 |
| 1026 | Childhood maltreatment | GCST90551844 | 4.45 |
| 1027 | Autorefraction - 3mm cylindrical power (right) | Eyesight | UKBB00000063 | 4.44 |
| 1028 | IGBP1 levels | GCST90469521 | 4.44 |
| 1029 | Spinal stenosis | musculoskeletal | UKBB00000792 | 4.44 |
| 1030 | aparc-DKTatlas lh area caudalmiddlefrontal | GCST90003236 | 4.44 |
| 1031 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T33 | ECGU000033 | 4.43 |
| 1032 | Systolic blood pressure | GCST90472780 | 4.43 |
| 1033 | FABP5 levels | GCST90469177 | 4.43 |
| 1034 | aparc-Desikan rh area cuneus | GCST90003111 | 4.42 |
| 1035 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T420 | ECGA000420 | 4.42 |
| 1036 | Optic cup area | GCST004137 | 4.42 |
| 1037 | Systolic blood pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000809 | 4.41 |
| 1038 | Tonsillectomy and adenotomy | FING00001367 | 4.41 |
| 1039 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 115) | GCST90320678 | 4.40 |
| 1040 | Ischemic heart disease (PheCode 411) | GCST90475929 | 4.40 |
| 1041 | Diastolic blood pressure, automated reading | Blood pressure | UKBB00000173 | 4.40 |
| 1042 | CCN5/IGFBP6 ratio | GCST90313723 | 4.40 |
| 1043 | aparc-DKTatlas lh volume parsopercularis | GCST90002878 | 4.40 |
| 1044 | CA2/TGM2 ratio | GCST90313582 | 4.39 |
| 1045 | AGER levels | GCST90012054 | 4.39 |
| 1046 | PON2/PON3 ratio | GCST90315703 | 4.38 |
| 1047 | ENPP7 levels | GCST90469118 | 4.38 |
| 1048 | PON3 levels | GCST90470287 | 4.38 |
| 1049 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T375 | ECGU000375 | 4.38 |
| 1050 | IDP dMRI TBSS MD Posterior thalamic radiation L | GCST90004056 | 4.38 |
| 1051 | Cerebrospinal fluid 3-hydroxy-2-ethylpropionate levels | GCST90317964 | 4.37 |
| 1052 | FHIT/PARK7 ratio | GCST90314821 | 4.37 |
| 1053 | DLK1/PIK3IP1 ratio | GCST90314492 | 4.37 |
| 1054 | Glaucoma | sense organs | UKBB00000287 | 4.36 |
| 1055 | IDP dMRI TBSS L3 Sagittal stratum L | GCST90004202 | 4.36 |
| 1056 | aparc-a2009s rh area G-pariet-inf-Angular | GCST90003395 | 4.36 |
| 1057 | PTPN1/TDRKH ratio | GCST90315745 | 4.35 |
| 1058 | wg lh intensity-contrast transversetemporal | GCST90003825 | 4.35 |
| 1059 | Metabolic disorder, other/unspecified | FING00000815 | 4.35 |
| 1060 | FGFR2 levels | GCST90469233 | 4.34 |
| 1061 | aparc-DKTatlas lh volume lingual | GCST90002873 | 4.34 |
| 1062 | Triacylglycerol_47:4_[M+NH4]1+ levels | GCST90060391 | 4.34 |
| 1063 | Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk | FING00000150 | 4.33 |
| 1064 | Physical activity (Total log acceleration 8am-10am) | GCST90061413 | 4.33 |
| 1065 | Inguinal hernia, bilateral | FING00000682 | 4.31 |
| 1066 | MIF/SUSD2 ratio | GCST90315452 | 4.31 |
| 1067 | Hypermetropia (PheCode 367.8) | GCST90475882 | 4.31 |
| 1068 | Disorders of breast | FING00000437 | 4.31 |
| 1069 | Chronic ischaemic heart disease | Ischaemic heart diseases | UKBB00000137 | 4.30 |
| 1070 | Left-hemisphere dorsal attention network to right-hemisphere dorsal attention network white-matter structural connectivity | GCST90302696 | 4.29 |
| 1071 | Cholesteryl ester (16:2) levels | GCST90024628 | 4.29 |
| 1072 | Diastolic blood pressure | GCST90301698 | 4.29 |
| 1073 | Systolic blood pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000808 | 4.29 |
| 1074 | Premature beats (PheCode 427.6) | GCST90475977 | 4.28 |
| 1075 | IDP dMRI ProbtrackX L2 ar l | GCST90004273 | 4.28 |
| 1076 | Cardiovascular disease | GCST90086057 | 4.28 |
| 1077 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T29 | ECGU000029 | 4.28 |
| 1078 | BA-exvivo rh thickness BA4a | GCST90003531 | 4.27 |
| 1079 | IDP dMRI TBSS L2 Cingulum hippocampus L | GCST90004160 | 4.27 |
| 1080 | aparc-a2009s lh volume S-postcentral | GCST90002991 | 4.27 |
| 1081 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T411 | ECGA000411 | 4.27 |
| 1082 | Cataract (PheCode 366) | GCST90043785 | 4.26 |
| 1083 | aparc-Desikan lh thickness paracentral | GCST90003461 | 4.25 |
| 1084 | DNAJA2/HPCAL1 ratio | GCST90314503 | 4.24 |
| 1085 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T366 | ECGU000366 | 4.24 |
| 1086 | ITGBL1 levels | GCST90469648 | 4.24 |
| 1087 | Haemorrhoids | Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified | UKBB00000294 | 4.24 |
| 1088 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 85) | GCST90320904 | 4.23 |
| 1089 | NPY levels | GCST90470081 | 4.23 |
| 1090 | QC dMRI-to-T1 linear alignment discrepancy | GCST90006351 | 4.23 |
| 1091 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T412 | ECGA000412 | 4.22 |
| 1092 | Retinal detachments and breaks | FING00001260 | 4.22 |
| 1093 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 78) | GCST90320897 | 4.22 |
| 1094 | CLK2 levels | GCST90240975 | 4.22 |
| 1095 | DTI TBSS L3 Posterior limb of internal capsule R | GCST90384542 | 4.22 |
| 1096 | TNFRSF4/TNFRSF9 ratio | GCST90315939 | 4.22 |
| 1097 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T24 | ECGU000024 | 4.21 |
| 1098 | Systolic blood pressure | GCST90310294 | 4.20 |
| 1099 | APOA2 levels | GCST90468332 | 4.20 |
| 1100 | Polyarthrosis | FING00001181 | 4.19 |
| 1101 | BMPER levels | GCST90468455 | 4.19 |
| 1102 | Volume of right whole amygdala | GCST90475054 | 4.19 |
| 1103 | IDP dMRI ProbtrackX L1 ilf r | GCST90004261 | 4.18 |
| 1104 | NRP1 levels | GCST90470085 | 4.18 |
| 1105 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T369 | ECGU000369 | 4.17 |
| 1106 | GPD1 levels | GCST90469388 | 4.17 |
| 1107 | Other chronic ischemic heart disease, unspecified | circulatory system | UKBB00000603 | 4.16 |
| 1108 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T419 | ECGA000419 | 4.16 |
| 1109 | DTI TBSS L3 Cingulum hippocampus R | GCST90384560 | 4.15 |
| 1110 | Left-hemisphere control network to thalamus white-matter structural connectivity | GCST90302752 | 4.15 |
| 1111 | NEO1 levels | GCST90470029 | 4.15 |
| 1112 | CR2/TNFRSF13B ratio | GCST90314225 | 4.14 |
| 1113 | Breast cancer | GCST004988 | 4.14 |
| 1114 | Osteoarthrosis NOS | musculoskeletal | UKBB00000597 | 4.14 |
| 1115 | IFIH1 levels | GCST90423689 | 4.14 |
| 1116 | Volume of left cortical nucleus | GCST90474964 | 4.13 |
| 1117 | APEX1/LSP1 ratio | GCST90313307 | 4.13 |
| 1118 | Volume of left whole amygdala | GCST90474988 | 4.12 |
| 1119 | CFHR4 levels | GCST90019045 | 4.12 |
| 1120 | SPARCL1 levels | GCST90470717 | 4.12 |
| 1121 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T44 | ECGU000044 | 4.11 |
| 1122 | Left ventricular end systole anterolateral wall thickness | GCST90278511 | 4.11 |
| 1123 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 80) | GCST90320643 | 4.11 |
| 1124 | ERP44 levels | GCST90469150 | 4.11 |
| 1125 | Kidney transplant status | FING00000710 | 4.11 |
| 1126 | DNAJB1/METAP2 ratio | GCST90314509 | 4.10 |
| 1127 | IDP dMRI ProbtrackX FA str l | GCST90003948 | 4.10 |
| 1128 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T235 | ECGA000235 | 4.10 |
| 1129 | PDGFB/SPARC ratio | GCST90315628 | 4.10 |
| 1130 | PTPN6/SNAP23 ratio | GCST90315747 | 4.10 |
| 1131 | IFNGR2 levels | GCST90469514 | 4.10 |
| 1132 | Spontaneous coronary artery dissection | GCST90245878 | 4.10 |
| 1133 | Lactose intolerance, other/unspecified | FING00000712 | 4.09 |
| 1134 | Treatment/medication code - co-codamol | Medications | UKBB00000845 | 4.09 |
| 1135 | aparc-Desikan rh volume parsopercularis | GCST90002818 | 4.08 |
| 1136 | DTI TBSS L2 Uncinate fasciculus L | GCST90384521 | 4.08 |
| 1137 | Operation code - wisdom teeth surgery | Operations | UKBB00000569 | 4.08 |
| 1138 | Olsenella C abundance in stool | GCST90032493 | 4.08 |
| 1139 | Disorders of muscles | FING00000444 | 4.08 |
| 1140 | Volume of right lateral nucleus | GCST90475034 | 4.07 |
| 1141 | aparc-a2009s lh thickness S-intrapariet+P-trans | GCST90003658 | 4.07 |
| 1142 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T365 | ECGU000365 | 4.07 |
| 1143 | NCR1 levels | GCST90090153 | 4.07 |
| 1144 | Snoring | GCST009763 | 4.07 |
| 1145 | Ischaemic heart disease, wide definition | FING00000703 | 4.05 |
| 1146 | CLUL1 levels | GCST90468792 | 4.05 |
| 1147 | Osteopenia or other disorder of bone and cartilage (PheCode 743.9) | GCST90476261 | 4.05 |
| 1148 | T1 FreeSurfer aseg Left-Inf-Lat-Vent | GCST90384140 | 4.05 |
| 1149 | aparc-DKTatlas rh volume precentral | GCST90002915 | 4.04 |
| 1150 | Systolic blood pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000805 | 4.04 |
| 1151 | ANGPTL3/TFPI ratio | GCST90313270 | 4.04 |
| 1152 | IDP dMRI TBSS MD Cingulum cingulate gyrus R | GCST90004061 | 4.04 |
| 1153 | BCAN/DPP6 ratio | GCST90313478 | 4.03 |
| 1154 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T399 | ECGA000399 | 4.03 |
| 1155 | CDH2/CDHR2 ratio | GCST90313950 | 4.03 |
| 1156 | Systolic blood pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000804 | 4.03 |
| 1157 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T367 | ECGU000367 | 4.02 |
| 1158 | Fracture of lower leg, including ankle | FING00000555 | 4.02 |
| 1159 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T418 | ECGA000418 | 4.02 |
| 1160 | Polyunsaturated fatty acids to total fatty acids percentage | GCST90502645 | 4.02 |
| 1161 | SNX15 levels | GCST90470699 | 4.02 |
| 1162 | Current employment status - Doing unpaid or voluntary work | Employment | UKBB00000157 | 4.01 |
| 1163 | LPCAT2 levels | GCST90241841 | 4.01 |
| 1164 | IDP dMRI TBSS ISOVF Fornix | GCST90004482 | 4.01 |
| 1165 | LY6D/PLA2G10 ratio | GCST90315345 | 4.01 |
| 1166 | ESAM/TGFB1 ratio | GCST90314718 | 4.00 |
| 1167 | IDP dMRI TBSS L3 Retrolenticular part of internal capsule R | GCST90004191 | 4.00 |
| 1168 | IDP dMRI TBSS MD Pontine crossing tract | GCST90004028 | 3.99 |
| 1169 | Ischemic heart disease (PheCode 411) | GCST008370 | 3.99 |
| 1170 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 45) | GCST90320608 | 3.99 |
| 1171 | IL1B levels | GCST90469570 | 3.98 |
| 1172 | PALM2 levels | GCST90470152 | 3.98 |
| 1173 | Macular cyst | FING00000743 | 3.98 |
| 1174 | BA-exvivo lh volume BA1 | GCST90002835 | 3.98 |
| 1175 | OCLN levels | GCST90470114 | 3.97 |
| 1176 | CD79B/FCRL2 ratio | GCST90313900 | 3.97 |
| 1177 | Systolic blood pressure (UKB data field 4080) | GCST90468179 | 3.96 |
| 1178 | Angina pectoris | FING00000086 | 3.96 |
| 1179 | Skin yellow/blue component | GCST90320259 | 3.95 |
| 1180 | Height | GCST90025949 | 3.95 |
| 1181 | PSME2/RBKS ratio | GCST90315737 | 3.95 |
| 1182 | Smoking dependency | FING00001315 | 3.95 |
| 1183 | Autorefraction - 3mm cylindrical power angle (left) | Eyesight | UKBB00000064 | 3.95 |
| 1184 | F9 levels | GCST90469172 | 3.95 |
| 1185 | Nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [LDH] (PheCode 573.6) | GCST90476094 | 3.95 |
| 1186 | TNFRSF12A levels | GCST90470904 | 3.95 |
| 1187 | Triacylglycerol_49:3_[M+NH4]1+ levels | GCST90060443 | 3.94 |
| 1188 | IDP dMRI TBSS FA Fornix | GCST90003882 | 3.94 |
| 1189 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T401 | ECGA000401 | 3.94 |
| 1190 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T77 | ECGA000077 | 3.94 |
| 1191 | Familial combined hyperlipidemia defined by Brunzell criteria | GCST90104003 | 3.94 |
| 1192 | GSR levels | GCST90469410 | 3.94 |
| 1193 | PGF levels | GCST90011999 | 3.93 |
| 1194 | Hard cardiovascular diseases | FING00000602 | 3.93 |
| 1195 | Nonalcoholic fatty liver disease | GCST90275041 | 3.92 |
| 1196 | BA-exvivo rh volume BA1 | GCST90002849 | 3.91 |
| 1197 | DLK1 levels | GCST90469003 | 3.91 |
| 1198 | wg lh intensity-contrast parsopercularis | GCST90003809 | 3.91 |
| 1199 | AHCY/HSPA1A ratio | GCST90313211 | 3.91 |
| 1200 | IDP dMRI ProbtrackX MD fmi | GCST90004230 | 3.90 |
| 1201 | IDP dMRI TBSS ICVF Cingulum hippocampus R | GCST90004363 | 3.90 |
| 1202 | Right-hemisphere limbic network to caudate white-matter structural connectivity | GCST90302828 | 3.90 |
| 1203 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T30 | ECGU000030 | 3.90 |
| 1204 | Aplastic anemia | GCST90018574 | 3.90 |
| 1205 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T32 | ECGU000032 | 3.90 |
| 1206 | Osteoarthritis | GCST90468144 | 3.90 |
| 1207 | DTI TBSS L2 Anterior corona radiata L | GCST90384499 | 3.89 |
| 1208 | DFFA levels | GCST90468987 | 3.89 |
| 1209 | Triacylglycerol (48:2) [NL-16:0] levels | GCST90025143 | 3.88 |
| 1210 | aparc-Desikan lh volume postcentral | GCST90002789 | 3.88 |
| 1211 | CRH levels | GCST90468862 | 3.88 |
| 1212 | Sphingomyelin_42:3_[M+H]1+ levels | GCST90060399 | 3.87 |
| 1213 | MCAM levels | GCST90469870 | 3.87 |
| 1214 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 28) | GCST90320847 | 3.86 |
| 1215 | PMVK levels | GCST90470272 | 3.86 |
| 1216 | Metabolonic lactone sulfate levels | GCST90200257 | 3.86 |
| 1217 | DNA methylation PhenoAge acceleration | GCST90014292 | 3.86 |
| 1218 | Blood cell traits latent factor 20 (red cell) | GCST90559262 | 3.86 |
| 1219 | CCDC80 levels | GCST90468562 | 3.86 |
| 1220 | SNCA levels | GCST90470694 | 3.86 |
| 1221 | CST6 levels | GCST90468896 | 3.85 |
| 1222 | wg lh intensity-contrast superiorfrontal | GCST90003819 | 3.85 |
| 1223 | HSPG2/VASN ratio | GCST90315094 | 3.85 |
| 1224 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T11 | ECGU000011 | 3.85 |
| 1225 | CD74/LILRB4 ratio | GCST90313894 | 3.84 |
| 1226 | CNST/ITGB1BP2 ratio | GCST90314158 | 3.84 |
| 1227 | AAMDC levels | GCST90468186 | 3.84 |
| 1228 | DNAJB1/STIP1 ratio | GCST90314513 | 3.84 |
| 1229 | Other hammer toe(s) (acquired) | FING00001054 | 3.83 |
| 1230 | IDP dMRI ProbtrackX L1 ifo l | GCST90004258 | 3.83 |
| 1231 | Left-hemisphere dorsal attention network to thalamus white-matter structural connectivity | GCST90302701 | 3.83 |
| 1232 | Glaucoma | Glaucoma | UKBB00000286 | 3.83 |
| 1233 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 23) | GCST90320842 | 3.82 |
| 1234 | aseg rh intensity Lateral-Ventricle | GCST90003778 | 3.82 |
| 1235 | GGT5 levels | GCST90469337 | 3.82 |
| 1236 | Myocardial infarction (PheCode 411.2) | GCST90475932 | 3.81 |
| 1237 | Osteoarthritis | GCST90134279 | 3.81 |
| 1238 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 127) | GCST90320690 | 3.81 |
| 1239 | DTI TBSS FA Posterior limb of internal capsule R | GCST90384398 | 3.81 |
| 1240 | IDP dMRI TBSS L3 Superior fronto-occipital fasciculus R | GCST90004213 | 3.81 |
| 1241 | ALKBH3 levels | GCST90619095 | 3.80 |
| 1242 | NCK2/PLA2G4A ratio | GCST90315524 | 3.80 |
| 1243 | Microscopic colitis | GCST90204144 | 3.80 |
| 1244 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T25 | ECGA000025 | 3.79 |
| 1245 | aparc-a2009s rh thickness G-postcentral | GCST90003704 | 3.79 |
| 1246 | STK11 levels | GCST90470765 | 3.79 |
| 1247 | Fracture of rib(s), sternum and thoracic spine | FING00000558 | 3.79 |
| 1248 | aseg rh volume Putamen | GCST90002639 | 3.79 |
| 1249 | CNTN5 levels | GCST90468807 | 3.78 |
| 1250 | NOTCH3/PTPRS ratio | GCST90315547 | 3.77 |
| 1251 | Bioavailable testosterone levels | GCST90012102 | 3.77 |
| 1252 | Barrett's esophagus or Esophageal adenocarcinoma | GCST003740 | 3.77 |
| 1253 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T234 | ECGA000234 | 3.77 |
| 1254 | IDP dMRI ProbtrackX L3 ar r | GCST90004301 | 3.76 |
| 1255 | Early lumbar disc prolapse, operated | FING00000484 | 3.76 |
| 1256 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T398 | ECGA000398 | 3.76 |
| 1257 | Left ventricular wall thickness (mean) | GCST90435264 | 3.76 |
| 1258 | MYOC/NOTCH3 ratio | GCST90315507 | 3.75 |
| 1259 | Total testosterone levels | GCST90239820 | 3.75 |
| 1260 | ADAMTS8/FAP ratio | GCST90313172 | 3.75 |
| 1261 | IDP dMRI TBSS FA Tapetum L | GCST90003924 | 3.75 |
| 1262 | Left ventricular end diastole inferior wall thickness | GCST90278515 | 3.75 |
| 1263 | T1 FreeSurfer aseg 4th-Ventricle | GCST90384148 | 3.74 |
| 1264 | aparc-a2009s lh area S-subparietal | GCST90003367 | 3.74 |
| 1265 | ANPEP/DPP4 ratio | GCST90313273 | 3.74 |
| 1266 | KDR/VWF ratio | GCST90315245 | 3.74 |
| 1267 | Retinal arteriolar tortuosity | GCST90270397 | 3.74 |
| 1268 | wg lh intensity-contrast entorhinal | GCST90003797 | 3.73 |
| 1269 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T374 | ECGU000374 | 3.73 |
| 1270 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T400 | ECGA000400 | 3.73 |
| 1271 | ADGRE5/NOTCH1 ratio | GCST90313181 | 3.73 |
| 1272 | Ischemic Heart Disease | circulatory system | UKBB00000381 | 3.73 |
| 1273 | Enteritis due to Yersinia enterocolitica | FING00000505 | 3.73 |
| 1274 | FKBP1B levels | GCST90469242 | 3.72 |
| 1275 | Ceramide (d18:2/22:0) levels | GCST90024682 | 3.72 |
| 1276 | DPP6 levels | GCST90469034 | 3.72 |
| 1277 | Osteoporosis | musculoskeletal | UKBB00000598 | 3.72 |
| 1278 | ASAH2 levels | GCST90242098 | 3.72 |
| 1279 | FABP4 levels | GCST90012075 | 3.71 |
| 1280 | Other disorders of veins | FING00001040 | 3.71 |
| 1281 | IDP dMRI TBSS MD Cingulum hippocampus R | GCST90004063 | 3.71 |
| 1282 | aparc-Desikan rh area pericalcarine | GCST90003127 | 3.71 |
| 1283 | Spherical power (left) | Autorefraction | UKBB00000790 | 3.71 |
| 1284 | Osteoporosis NOS | musculoskeletal | UKBB00000599 | 3.71 |
| 1285 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T368 | ECGU000368 | 3.71 |
| 1286 | HJV levels | GCST90469455 | 3.71 |
| 1287 | TNFSF11 levels | GCST90012044 | 3.71 |
| 1288 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 6) | GCST90320825 | 3.70 |
| 1289 | aparc-a2009s rh area G-oc-temp-med-Lingual | GCST90003392 | 3.70 |
| 1290 | ASGR1/GGT5 ratio | GCST90313365 | 3.70 |
| 1291 | Presence of cardiac and vascular implants and grafts | Persons with potential health hazards related to family and personal history and certain conditions influencing health status | UKBB00000708 | 3.70 |
| 1292 | IDP dMRI TBSS L2 Retrolenticular part of internal capsule L | GCST90004144 | 3.70 |
| 1293 | Total protein levels | GCST90018756 | 3.69 |
| 1294 | IDP dMRI ProbtrackX FA ifo r | GCST90003938 | 3.69 |
| 1295 | Diastolic blood pressure (UKB data field 4079) | GCST90468163 | 3.69 |
| 1296 | Myocardial infarction | GCST90018657 | 3.68 |
| 1297 | RNASEH2A levels | GCST90470480 | 3.68 |
| 1298 | IDP dMRI ProbtrackX L2 fma | GCST90004283 | 3.67 |
| 1299 | MED18/SMAD1 ratio | GCST90315413 | 3.67 |
| 1300 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T28 | ECGU000028 | 3.67 |
| 1301 | Non-cancer illness code, self-reported - migraine | Medical conditions | UKBB00000520 | 3.66 |
| 1302 | DTI TBSS L3 Anterior corona radiata L | GCST90384547 | 3.66 |
| 1303 | GPA33 levels | GCST90469385 | 3.66 |
| 1304 | CNTN4 levels | GCST90468806 | 3.66 |
| 1305 | aparc-a2009s lh volume G-cingul-Post-ventral | GCST90002934 | 3.65 |
| 1306 | IDP T1 FAST ROIs R intracalc cortex | GCST90002498 | 3.65 |
| 1307 | Heart valve disorders (PheCode 395) | GCST90475913 | 3.65 |
| 1308 | FLI1 levels | GCST90469247 | 3.65 |
| 1309 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 50) | GCST90320613 | 3.65 |
| 1310 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T364 | ECGU000364 | 3.65 |
| 1311 | Hemangioma of skin and subcutaneous tissue (PheCode 228.1) | GCST90475633 | 3.65 |
| 1312 | DIABLO/PRKAR1A ratio | GCST90314469 | 3.65 |
| 1313 | Phosphatidylcholine-O_34:2_[M+H]1+/Phosphatidylcholine-P_34:1_[M+H]1+/Phosphatidylethanolamine-O_37:2_[M+H]1+ levels | GCST90060280 | 3.64 |
| 1314 | HNRNPUL1 levels | GCST90469470 | 3.64 |
| 1315 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T34 | ECGU000034 | 3.64 |
| 1316 | COL3A1 levels | GCST90468817 | 3.64 |
| 1317 | N-acetylglycine levels | GCST90243561 | 3.64 |
| 1318 | ATXN10/SLC27A4 ratio | GCST90313399 | 3.64 |
| 1319 | DBH levels | GCST90468948 | 3.63 |
| 1320 | Polyp of the female genital tract | FING00001190 | 3.62 |
| 1321 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T18 | ECGA000018 | 3.62 |
| 1322 | Diseases of external ear | FING00000424 | 3.62 |
| 1323 | IDP dMRI ProbtrackX MD cst l | GCST90004227 | 3.62 |
| 1324 | LEPR/NTRK2 ratio | GCST90315313 | 3.62 |
| 1325 | SESTD1 levels | GCST90470604 | 3.61 |
| 1326 | DTI TBSS L1 Splenium of corpus callosum | GCST90384432 | 3.61 |
| 1327 | ACVRL1/TNFRSF19 ratio | GCST90313159 | 3.61 |
| 1328 | aseg global intensity WM-hypointensities | GCST90003756 | 3.60 |
| 1329 | Fracture of lower limb | injuries & poisonings | UKBB00000255 | 3.60 |
| 1330 | T1 FreeSurfer a2009s lh G precentral volume | GCST90384844 | 3.60 |
| 1331 | IDP dMRI ProbtrackX FA ilf r | GCST90003940 | 3.60 |
| 1332 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T231 | ECGA000231 | 3.60 |
| 1333 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T421 | ECGA000421 | 3.59 |
| 1334 | BAX levels | GCST90468424 | 3.59 |
| 1335 | aparc-DKTatlas rh thickness cuneus | GCST90003574 | 3.59 |
| 1336 | Hair/balding pattern: Pattern 1 (UKB data field 2395_1) | GCST90043616 | 3.58 |
| 1337 | Operative procedures - Haemorrhoidectomy | Summary Operations | UKBB00000580 | 3.58 |
| 1338 | SLC39A5 levels | GCST90470661 | 3.58 |
| 1339 | ALB levels | GCST90025992 | 3.58 |
| 1340 | Autorefraction - 6mm asymmetry angle (left) | Eyesight | UKBB00000072 | 3.58 |
| 1341 | Coronary artery bypass grafting | FING00000358 | 3.58 |
| 1342 | APP/CD40LG ratio | GCST90313319 | 3.58 |
| 1343 | DPT levels | GCST90469036 | 3.57 |
| 1344 | IDP dMRI ProbtrackX L2 ar r | GCST90004274 | 3.57 |
| 1345 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T370 | ECGU000370 | 3.57 |
| 1346 | wg lh intensity-contrast bankssts | GCST90003793 | 3.57 |
| 1347 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T45 | ECGU000045 | 3.57 |
| 1348 | Medication use (agents acting on the renin-angiotensin system) | GCST90018768 | 3.57 |
| 1349 | AKR1B1 levels | GCST90468273 | 3.57 |
| 1350 | HHEX levels | GCST90469451 | 3.57 |
| 1351 | Dihexosylceramide (d18:1/22:0) levels | GCST90025348 | 3.56 |
| 1352 | Other disorders of eyelid | FING00001026 | 3.56 |
| 1353 | IDP dMRI TBSS OD Superior corona radiata R | GCST90004426 | 3.56 |
| 1354 | BA-exvivo lh area V1 | GCST90003216 | 3.55 |
| 1355 | Pulmonary tuberculosis | GCST90018672 | 3.55 |
| 1356 | ITGA11 levels | GCST90469633 | 3.54 |
| 1357 | CREG1/NAAA ratio | GCST90314250 | 3.54 |
| 1358 | PSAP levels | GCST90470351 | 3.53 |
| 1359 | Acetabular diameter | GCST90448906 | 3.53 |
| 1360 | Osteomyelitis (PheCode 710.1) | GCST90476221 | 3.52 |
| 1361 | DTI TBSS L3 Anterior corona radiata R | GCST90384546 | 3.52 |
| 1362 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T72 | ECGU000072 | 3.52 |
| 1363 | Operative procedures - Carpal tunnel release | Summary Operations | UKBB00000574 | 3.52 |
| 1364 | GDNF levels | GCST90469323 | 3.52 |
| 1365 | Forced expiratory volume (baseline) | GCST90565844 | 3.51 |
| 1366 | Unspecified osteomyelitis (PheCode 710.19) | GCST90476224 | 3.51 |
| 1367 | TBC1D5 levels | GCST90470811 | 3.51 |
| 1368 | IDP dMRI TBSS L2 Posterior corona radiata R | GCST90004149 | 3.51 |
| 1369 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 107) | GCST90320670 | 3.51 |
| 1370 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T27 | ECGU000027 | 3.50 |
| 1371 | BA-exvivo rh area V2 | GCST90003231 | 3.50 |
| 1372 | IDP dMRI TBSS FA Tapetum R | GCST90003923 | 3.50 |
| 1373 | Triacylglycerol_50:4_[M+NH4]1+ levels | GCST90060466 | 3.50 |
| 1374 | Rectal cancer | GCST90011810 | 3.50 |
| 1375 | IDP T2 FLAIR BIANCA WMH volume | GCST90003862 | 3.50 |
| 1376 | CFB levels | GCST90240778 | 3.49 |
| 1377 | MTIF3 levels | GCST90469957 | 3.49 |
| 1378 | GFRA1 levels | GCST90469328 | 3.48 |
| 1379 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T376 | ECGU000376 | 3.48 |
| 1380 | aseg lh intensity Accumbens-area | GCST90003774 | 3.48 |
| 1381 | Hernia abdominopelvic cavity | GCST90086087 | 3.48 |
| 1382 | SEL1L levels | GCST90470564 | 3.48 |
| 1383 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 98) | GCST90320661 | 3.47 |
| 1384 | Aneurysm of iliac artery (PheCode 442.2) | GCST90475995 | 3.47 |
| 1385 | Glomerular filtration rate (cystatin C) | GCST003375 | 3.47 |
| 1386 | Humerus length to body height ratio | GCST90270259 | 3.47 |
| 1387 | MEGF9 levels | GCST90469884 | 3.47 |
| 1388 | Cholesteryl ester_18:0_[M+NH4]1+ levels | GCST90060222 | 3.47 |
| 1389 | ADAMTS8 levels | GCST90468227 | 3.46 |
| 1390 | TNFRSF11B levels | GCST90243158 | 3.46 |
| 1391 | CLEC1B/MGLL ratio | GCST90314097 | 3.46 |
| 1392 | Right-hemisphere visual network to accumbens white-matter structural connectivity | GCST90302787 | 3.46 |
| 1393 | aparc-DKTatlas rh volume parstriangularis | GCST90002911 | 3.46 |
| 1394 | PTPRZ1 levels | GCST90470388 | 3.45 |
| 1395 | AIFM1/PLXNA4 ratio | GCST90313220 | 3.45 |
| 1396 | IDP dMRI TBSS MO Retrolenticular part of internal capsule R | GCST90003972 | 3.45 |
| 1397 | IDP dMRI TBSS MO Fornix | GCST90003957 | 3.44 |
| 1398 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T379 | ECGU000379 | 3.44 |
| 1399 | MSRA/P4HB ratio | GCST90315495 | 3.43 |
| 1400 | Hippocampal subfield left CA3 volume (body) | GCST90267940 | 3.42 |
| 1401 | TNFSF14 levels | GCST90274842 | 3.42 |
| 1402 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T378 | ECGU000378 | 3.41 |
| 1403 | wg rh intensity-contrast parsorbitalis | GCST90003845 | 3.41 |
| 1404 | Breast cancer | GCST010098 | 3.41 |
| 1405 | CACNB3 levels | GCST90468523 | 3.41 |
| 1406 | Hydrocephalus | FING00000628 | 3.40 |
| 1407 | IDP dMRI TBSS L2 Tapetum L | GCST90004170 | 3.40 |
| 1408 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T236 | ECGA000236 | 3.40 |
| 1409 | 10-undecenoate (11:1n1) levels | GCST90243596 | 3.40 |
| 1410 | Microalbumin urine | GCST90278639 | 3.40 |
| 1411 | CTSZ/NAAA ratio | GCST90314320 | 3.40 |
| 1412 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T46 | ECGU000046 | 3.39 |
| 1413 | CDKN1A/TBL1X ratio | GCST90313977 | 3.39 |
| 1414 | triglyceride (minimum, inv-norm transformed) | GCST90476439 | 3.39 |
| 1415 | Paroxysmal tachycardia | FING00001151 | 3.39 |
| 1416 | BAMBI levels | GCST90468420 | 3.38 |
| 1417 | PI16 levels | GCST90470229 | 3.38 |
| 1418 | Liver volume (adjusted for height) | GCST90566819 | 3.38 |
| 1419 | IDP dMRI ProbtrackX ICVF unc l | GCST90004400 | 3.37 |
| 1420 | End-diastolic bi-ventricular shape (principal component 3) | GCST90448482 | 3.37 |
| 1421 | ThalamNuclei lh volume CeM | GCST90002725 | 3.37 |
| 1422 | Non-seminoma of testis, excluding all cancers (controls excluding all cancers) | FING00000874 | 3.37 |
| 1423 | Benign leiomyoma with endometriosis (controls excluding all cancers) | FING00000145 | 3.36 |
| 1424 | wg rh intensity-contrast parsopercularis | GCST90003844 | 3.36 |
| 1425 | Disorders of iris and ciliary body (PheCode 379.5) | GCST90475899 | 3.36 |
| 1426 | Sphingomyelin_41:0_[M+H]1+ levels | GCST90060386 | 3.36 |
| 1427 | IDP dMRI ProbtrackX ICVF cgh l | GCST90004381 | 3.36 |
| 1428 | Systolic blood pressure | GCST90018752 | 3.35 |
| 1429 | IDP dMRI ProbtrackX MD cgc l | GCST90004223 | 3.35 |
| 1430 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T14 | ECGU000014 | 3.35 |
| 1431 | aseg lh volume Caudate | GCST90002621 | 3.35 |
| 1432 | Myocardial infarction (PheCode 411.2) | GCST90043954 | 3.35 |
| 1433 | T1 CAT volume Vermis VIIIa | GCST90384128 | 3.35 |
| 1434 | IDP dMRI TBSS MD Superior longitudinal fasciculus L | GCST90004068 | 3.34 |
| 1435 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T45 | ECGA000045 | 3.34 |
| 1436 | ELAC1 levels | GCST90469101 | 3.34 |
| 1437 | GRAP2/SNX9 ratio | GCST90314988 | 3.34 |
| 1438 | CIAPIN1/SNAP29 ratio | GCST90314067 | 3.33 |
| 1439 | SNAP29/SNX9 ratio | GCST90315859 | 3.33 |
| 1440 | Spondylolisthesis/Spondylolysis | FING00001324 | 3.32 |
| 1441 | triglyceride (maximum, inv-norm transformed) | GCST90476431 | 3.32 |
| 1442 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T106 | ECGA000106 | 3.32 |
| 1443 | CD40LG/EREG ratio | GCST90313820 | 3.31 |
| 1444 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T67 | ECGU000067 | 3.31 |
| 1445 | Systolic blood pressure | GCST90301696 | 3.30 |
| 1446 | Prescriptions - amlodipine | calcium channel blocker,dihydropyridine,anti-hypertensive | UKBB00000660 | 3.30 |
| 1447 | KIAA0040 levels | GCST90422552 | 3.29 |
| 1448 | aparc-DKTatlas lh volume caudalmiddlefrontal | GCST90002864 | 3.29 |
| 1449 | aparc-a2009s rh area S-calcarine | GCST90003414 | 3.29 |
| 1450 | MUC16 levels | GCST90469964 | 3.29 |
| 1451 | IDP dMRI TBSS L3 Retrolenticular part of internal capsule L | GCST90004192 | 3.29 |
| 1452 | Osteoporosis, osteopenia and pathological fracture | musculoskeletal | UKBB00000600 | 3.29 |
| 1453 | Other menopausal disorders | FING00001071 | 3.28 |
| 1454 | SMAD1 levels | GCST90470675 | 3.27 |
| 1455 | TBCA levels | GCST90470812 | 3.27 |
| 1456 | BTN2A1/SMOC2 ratio | GCST90313549 | 3.27 |
| 1457 | CA1/TGM2 ratio | GCST90313575 | 3.27 |
| 1458 | Other intervertebral disc disorders | FING00001063 | 3.27 |
| 1459 | Volume of left accessory basal nucleus | GCST90474940 | 3.27 |
| 1460 | Varicose veins of lower extremities | Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified | UKBB00000894 | 3.27 |
| 1461 | OLR1/PLAUR ratio | GCST90315584 | 3.27 |
| 1462 | Thoracic or lumbosacral neuritis or radiculitis, unspecified (PheCode 763) | GCST90476268 | 3.27 |
| 1463 | aparc-DKTatlas rh area pericalcarine | GCST90003284 | 3.27 |
| 1464 | SRSF7 levels | GCST90242771 | 3.26 |
| 1465 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 83) | GCST90320646 | 3.26 |
| 1466 | End-diastolic bi-ventricular shape (principal component 9) | GCST90448488 | 3.26 |
| 1467 | PRTG levels | GCST90470347 | 3.26 |
| 1468 | aparc-a2009s rh volume S-orbital-H-Shaped | GCST90003062 | 3.26 |
| 1469 | aparc-DKTatlas rh thickness transversetemporal | GCST90003601 | 3.26 |
| 1470 | DNER levels | GCST90469019 | 3.26 |
| 1471 | BA-exvivo lh volume V2 | GCST90002845 | 3.25 |
| 1472 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 104) | GCST90320667 | 3.25 |
| 1473 | Polyunsaturated fatty acids to saturated fatty acids ratio | GCST90502580 | 3.24 |
| 1474 | BSG/LAMP3 ratio | GCST90313533 | 3.24 |
| 1475 | Temporomandibular joint disorders, including avohilmo | FING00001355 | 3.24 |
| 1476 | triglyceride (mean, inv-norm transformed) | GCST90476435 | 3.23 |
| 1477 | IDP dMRI TBSS L1 Corticospinal tract R | GCST90004081 | 3.23 |
| 1478 | BA-exvivo lh thickness V2 | GCST90003523 | 3.23 |
| 1479 | Illnesses of mother - High blood pressure | Family history | UKBB00000348 | 3.23 |
| 1480 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T68 | ECGU000068 | 3.23 |
| 1481 | AOC3/ITGB1 ratio | GCST90313295 | 3.23 |
| 1482 | IDP dMRI TBSS ICVF Fornix | GCST90004332 | 3.21 |
| 1483 | Triacylglycerol_48:3_[M+NH4]1+ levels | GCST90060418 | 3.21 |
| 1484 | REN levels | GCST90470454 | 3.21 |
| 1485 | wg rh intensity-contrast frontalpole | GCST90003858 | 3.20 |
| 1486 | ESAM levels | GCST90469152 | 3.20 |
| 1487 | LTA/LTBR ratio | GCST90315336 | 3.20 |
| 1488 | ANPEP levels | GCST90468313 | 3.20 |
| 1489 | CX3CL1 levels | GCST90274778 | 3.19 |
| 1490 | Sphingomyelin_40:0_[M+H]1+ levels | GCST90060364 | 3.19 |
| 1491 | PTGES2 levels | GCST90470369 | 3.19 |
| 1492 | MIA levels | GCST90469903 | 3.19 |
| 1493 | Right-hemisphere somatomotor network to putamen white-matter structural connectivity | GCST90302796 | 3.19 |
| 1494 | DNAJB1/EIF4B ratio | GCST90314508 | 3.19 |
| 1495 | HippSubfield lh volume GC-ML-DG-body | GCST90002681 | 3.19 |
| 1496 | Unspecified monoarthritis | musculoskeletal | UKBB00000882 | 3.18 |
| 1497 | Autorefraction - 3mm weak meridian angle (left) | Eyesight | UKBB00000071 | 3.18 |
| 1498 | ATP5IF1/LYN ratio | GCST90313389 | 3.18 |
| 1499 | APP/NID2 ratio | GCST90313327 | 3.18 |
| 1500 | CD40/GLOD4 ratio | GCST90313814 | 3.17 |
| 1501 | Skin red/green component | GCST90320258 | 3.17 |
| 1502 | NOS3 levels | GCST90470064 | 3.17 |
| 1503 | FSTL1 levels | GCST90469271 | 3.17 |
| 1504 | PILRA levels | GCST90470236 | 3.17 |
| 1505 | CHI3L1/HSPG2 ratio | GCST90314043 | 3.17 |
| 1506 | Atherosclerosis (PheCode 440) | GCST90475989 | 3.16 |
| 1507 | IDP dMRI ProbtrackX L3 fma | GCST90004310 | 3.16 |
| 1508 | IDP dMRI ProbtrackX L3 ar l | GCST90004300 | 3.16 |
| 1509 | UFD1 levels | GCST90471005 | 3.15 |
| 1510 | red blood cell count (RBC, maximum, inv-norm transformed) | GCST90476343 | 3.15 |
| 1511 | Cerebral aneurysm, nonruptured | FING00000263 | 3.14 |
| 1512 | Femoral hernia | FING00000540 | 3.14 |
| 1513 | C3 levels | GCST90281041 | 3.14 |
| 1514 | CDH5 levels | GCST90468676 | 3.14 |
| 1515 | aparc-Desikan rh volume precentral | GCST90002824 | 3.13 |
| 1516 | Left-hemisphere salience/ventral attention network to right-hemisphere somatomotor network white-matter structural connectivity | GCST90302713 | 3.13 |
| 1517 | Cardiomyopathy | GCST90399705 | 3.13 |
| 1518 | T1 FreeSurfer BA rh V2 exvivo thickness | GCST90385571 | 3.12 |
| 1519 | Lung function (FEV1/FVC) | GCST90025978 | 3.12 |
| 1520 | Systolic blood pressure | GCST90472781 | 3.12 |
| 1521 | Adenocarcinoma and papilloma adenocarcinoma of rectum | FING00000039 | 3.12 |
| 1522 | Chronic obstructive pulmonary disease | GCST90018587 | 3.12 |
| 1523 | wg lh intensity-contrast fusiform | GCST90003798 | 3.11 |
| 1524 | Right-hemisphere salience/ventral attention network to thalamus white-matter structural connectivity | GCST90302817 | 3.11 |
| 1525 | Other peripheral nerve disorders (PheCode 351) | GCST90475842 | 3.11 |
| 1526 | Volume of left cortical nucleus | GCST90474886 | 3.11 |
| 1527 | Acylcarnitine (18:2) levels | GCST90024623 | 3.10 |
| 1528 | IL13RA1 levels | GCST90469552 | 3.10 |
| 1529 | Breast conditions, congenital or relating to hormones (PheCode 612) | GCST90476162 | 3.10 |
| 1530 | BGLAP levels | GCST90468440 | 3.09 |
| 1531 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T238 | ECGA000238 | 3.09 |
| 1532 | ECE1 levels | GCST90469061 | 3.09 |
| 1533 | Memory loss or impairment | GCST90475544 | 3.09 |
| 1534 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 36) | GCST90320599 | 3.09 |
| 1535 | IDP dMRI TBSS L2 Retrolenticular part of internal capsule R | GCST90004143 | 3.08 |
| 1536 | Diastolic blood pressure | GCST90301699 | 3.08 |
| 1537 | Systolic blood pressure (MTAG) | GCST90449056 | 3.08 |
| 1538 | Left-hemisphere dorsal attention network to right-hemisphere default mode network white-matter structural connectivity | GCST90302700 | 3.08 |
| 1539 | IDP dMRI TBSS MD Corticospinal tract R | GCST90004033 | 3.08 |
| 1540 | CD300LG/DSG2 ratio | GCST90313802 | 3.07 |
| 1541 | CA6 levels | GCST90468515 | 3.07 |
| 1542 | EGFLAM levels | GCST90421651 | 3.07 |
| 1543 | RBP7 levels | GCST90470440 | 3.07 |
| 1544 | Lysoalkylphosphatidylcholine (O-24:0) levels | GCST90024812 | 3.07 |
| 1545 | Pulse wave peak to peak time | Arterial stiffness | UKBB00000725 | 3.06 |
| 1546 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T397 | ECGA000397 | 3.06 |
| 1547 | Female infertility | FING00000536 | 3.06 |
| 1548 | Endometriosis ASRM stages 3,4 | FING00000498 | 3.06 |
| 1549 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 81) | GCST90320644 | 3.06 |
| 1550 | Deep endometriosis | FING00000382 | 3.06 |
| 1551 | SLC27A4 levels | GCST90470657 | 3.05 |
| 1552 | PRTFDC1 levels | GCST90470346 | 3.05 |
| 1553 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T23 | ECGU000023 | 3.05 |
| 1554 | Isoleucine levels (UKB data field 23465) | GCST90269562 | 3.05 |
| 1555 | CCL14 levels | GCST90468566 | 3.05 |
| 1556 | PCYT2 levels | GCST90470178 | 3.05 |
| 1557 | Omega-6 fatty acids to total fatty acids percentage | GCST90502541 | 3.05 |
| 1558 | CNP levels | GCST90468798 | 3.04 |
| 1559 | CD244/FCRL6 ratio | GCST90313765 | 3.04 |
| 1560 | aparc-Desikan rh thickness transversetemporal | GCST90003511 | 3.03 |
| 1561 | T1 FreeSurfer aseg Right-Lateral-Ventricle | GCST90384157 | 3.03 |
| 1562 | IDP T1 FIRST right putamen volume | GCST90002441 | 3.03 |
| 1563 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T22 | ECGU000022 | 3.03 |
| 1564 | LEPR levels | GCST90469756 | 3.02 |
| 1565 | Atrial septal defect | FING00000128 | 3.02 |
| 1566 | DLK1/RGMB ratio | GCST90314493 | 3.02 |
| 1567 | IDP dMRI ProbtrackX FA ar r | GCST90003926 | 3.02 |
| 1568 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T101 | ECGA000101 | 3.02 |
| 1569 | aparc-pial rh area lingual | GCST90003186 | 3.02 |
| 1570 | aparc-Desikan lh volume caudalmiddlefrontal | GCST90002771 | 3.02 |
| 1571 | Abdominal aortic calcification levels | GCST90134614 | 3.01 |
| 1572 | IDP T1 FAST ROIs R planum temporale | GCST90002542 | 3.01 |
| 1573 | Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers) | FING00000316 | 3.01 |
| 1574 | aparc-a2009s rh thickness G-cuneus | GCST90003687 | 3.01 |
| 1575 | Spondylosis | FING00001327 | 3.01 |
| 1576 | Omega-6 fatty acids to omega-3 fatty acids ratio | GCST90499194 | 3.01 |
| 1577 | IDP dMRI TBSS L2 Superior corona radiata R | GCST90004147 | 3.00 |
| 1578 | ESAM/FUT8 ratio | GCST90314711 | 3.00 |
| 1579 | CCN3/PGF ratio | GCST90313722 | 3.00 |
| 1580 | IDP dMRI TBSS L3 Superior fronto-occipital fasciculus L | GCST90004214 | 3.00 |
| 1581 | Other disorders of cornea | FING00001022 | 3.00 |
| 1582 | T1 FreeSurfer aseg 3rd-Ventricle | GCST90384147 | 2.99 |
| 1583 | Frozen shoulder | GCST90000513 | 2.99 |
| 1584 | GADD45GIP1 levels | GCST90469293 | 2.99 |
| 1585 | SERPINA3 levels | GCST90470583 | 2.98 |
| 1586 | Triglyceride to HDL cholesterol ratio | GCST90295949 | 2.98 |
| 1587 | AXL levels | GCST90468406 | 2.97 |
| 1588 | TSTA3 levels | GCST90421854 | 2.97 |
| 1589 | Female infertility, associated with anovulation | FING00000537 | 2.97 |
| 1590 | BA-exvivo lh volume BA4p | GCST90002840 | 2.97 |
| 1591 | Excessive hairiness | GCST006095 | 2.97 |
| 1592 | GFRA3 levels | GCST90469330 | 2.97 |
| 1593 | Docosahexaenoic acid levels (UKB data field 23450) | GCST90269547 | 2.97 |
| 1594 | CPXM2 levels | GCST90468850 | 2.97 |
| 1595 | IL16 levels | GCST90241596 | 2.97 |
| 1596 | Pulse pressure | GCST90018750 | 2.97 |
| 1597 | Isoleucine levels | GCST90092843 | 2.96 |
| 1598 | End-diastolic bi-ventricular shape (principal component 1) | GCST90448480 | 2.96 |
| 1599 | Peripheral vascular disease | GCST90475996 | 2.96 |
| 1600 | Phospholipids to total lipids ratio in large VLDL | GCST90092877 | 2.95 |
| 1601 | Phosphatidylcholine_34:2_[M+H]1+/Phosphatidylethanolamine_37:2_[M+H]1+/Phosphatidate_39:3_[M+NH4]1+ levels | GCST90060303 | 2.95 |
| 1602 | Age-related macular degeneration | GCST90086111 | 2.95 |
| 1603 | Diastolic blood pressure | GCST90472777 | 2.95 |
| 1604 | Diastolic blood pressure | GCST90310295 | 2.95 |
| 1605 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T237 | ECGA000237 | 2.95 |
| 1606 | Hypoplasia of dental enamel, including avohilmo | FING00000652 | 2.95 |
| 1607 | IDP dMRI TBSS ISOVF Superior longitudinal fasciculus L | GCST90004518 | 2.94 |
| 1608 | MB levels | GCST90012047 | 2.94 |
| 1609 | Left-hemisphere limbic network to right-hemisphere limbic network white-matter structural connectivity | GCST90302733 | 2.94 |
| 1610 | Prescriptions - calcium channel blocker|dihydropyridine|anti-hypertensive | UKBB00000673 | 2.94 |
| 1611 | Peripheral vascular disease, unspecified (PheCode 443.9) | GCST90475998 | 2.94 |
| 1612 | GPI levels | GCST90241269 | 2.93 |
| 1613 | DYNLL1 levels | GCST90240984 | 2.93 |
| 1614 | Treatment speciality of consultant (recoded) - Cardiology | Summary Administration | UKBB00000829 | 2.93 |
| 1615 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T44 | ECGA000044 | 2.93 |
| 1616 | 1,2-dipalmitoyl-GPC (16:0/16:0) metabolite level | GCST90615438 | 2.93 |
| 1617 | Acetate levels (UKB data field 23475) | GCST90269572 | 2.92 |
| 1618 | EGLN1/LSP1 ratio | GCST90314617 | 2.92 |
| 1619 | 5-oxoproline levels | GCST90243437 | 2.91 |
| 1620 | CDH5/ENG ratio | GCST90313954 | 2.91 |
| 1621 | Coronary heart disease | GCST000998 | 2.91 |
| 1622 | DNAJB1 levels | GCST90469012 | 2.91 |
| 1623 | Diastolic blood pressure | GCST90025981 | 2.91 |
| 1624 | Noninflammatory disorders of female genital tract | FING00000882 | 2.90 |
| 1625 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T107 | ECGA000107 | 2.90 |
| 1626 | IGF1 levels | GCST90468078 | 2.90 |
| 1627 | Gamma-CEHC levels | GCST90199864 | 2.90 |
| 1628 | DNM1 levels | GCST90469021 | 2.89 |
| 1629 | aparc-DKTatlas lh volume postcentral | GCST90002882 | 2.89 |
| 1630 | Familial combined hyperlipidemia defined by Mexico criteria | GCST90104007 | 2.89 |
| 1631 | IDP dMRI TBSS L3 Uncinate fasciculus R | GCST90004215 | 2.88 |
| 1632 | PLA2G4A/PPP1R12A ratio | GCST90315666 | 2.87 |
| 1633 | IRAK1 levels | GCST90469627 | 2.87 |
| 1634 | BLVRB/CA2 ratio | GCST90313522 | 2.87 |
| 1635 | Total testosterone levels | GCST90012112 | 2.87 |
| 1636 | FNDC1 levels | GCST90469256 | 2.86 |
| 1637 | wg rh intensity-contrast superiorfrontal | GCST90003854 | 2.86 |
| 1638 | 4-androsten-3beta,17beta-diol disulfate 2 levels | GCST90243880 | 2.86 |
| 1639 | NDUFB7 levels | GCST90470015 | 2.85 |
| 1640 | Calculus of lower urinary tract | FING00000237 | 2.85 |
| 1641 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T422 | ECGA000422 | 2.85 |
| 1642 | TNR levels | GCST90470929 | 2.85 |
| 1643 | Mandibular retrognathia | FING00000784 | 2.85 |
| 1644 | aparc-pial rh area parstriangularis | GCST90003193 | 2.85 |
| 1645 | LGALS8/VWF ratio | GCST90315322 | 2.85 |
| 1646 | End-diastolic bi-ventricular shape (principal component 10) | GCST90448489 | 2.84 |
| 1647 | Inguinal hernia | GCST90018648 | 2.84 |
| 1648 | IDP dMRI TBSS L3 Posterior thalamic radiation L | GCST90004200 | 2.84 |
| 1649 | IDP dMRI ProbtrackX L2 ptr r | GCST90004293 | 2.84 |
| 1650 | Cardiomyopathy | FING00000250 | 2.82 |
| 1651 | IDP dMRI TBSS L3 Posterior thalamic radiation R | GCST90004199 | 2.82 |
| 1652 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T107 | ECGU000107 | 2.82 |
| 1653 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T380 | ECGU000380 | 2.82 |
| 1654 | Volume of right whole amygdala | GCST90474931 | 2.82 |
| 1655 | HPCAL1/MPIG6B ratio | GCST90315073 | 2.81 |
| 1656 | Frequency of heavy DIY in last 4 weeks | Physical activity | UKBB00000263 | 2.81 |
| 1657 | Birth weight | Early life factors | UKBB00000095 | 2.81 |
| 1658 | Mean bone marrow fat fraction of left and right proximal femur | GCST90652394 | 2.80 |
| 1659 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T37 | ECGA000037 | 2.80 |
| 1660 | ISLR2 levels | GCST90469629 | 2.80 |
| 1661 | IDP dMRI ProbtrackX FA fmi | GCST90003936 | 2.80 |
| 1662 | CAPG levels | GCST90468537 | 2.80 |
| 1663 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T377 | ECGU000377 | 2.80 |
| 1664 | Hippocampal right GC-ML-DG volume (head) | GCST90267968 | 2.79 |
| 1665 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 93) | GCST90320912 | 2.78 |
| 1666 | Diastolic blood pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000178 | 2.78 |
| 1667 | IDP dMRI TBSS L2 Posterior limb of internal capsule R | GCST90004141 | 2.78 |
| 1668 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T363 | ECGU000363 | 2.78 |
| 1669 | LTBR levels | GCST90243176 | 2.78 |
| 1670 | DTI TBSS MD Uncinate fasciculus R | GCST90384616 | 2.78 |
| 1671 | Osteoporosis | GCST90086122 | 2.78 |
| 1672 | Saturated fatty acids to total fatty acids percentage | GCST90502205 | 2.77 |
| 1673 | STAT5B levels | GCST90470759 | 2.76 |
| 1674 | CD300LG levels | GCST90468623 | 2.76 |
| 1675 | Chronic rhinitis, nasopharyngitis and pharyngitis | FING00000297 | 2.75 |
| 1676 | DOK2/PDLIM7 ratio | GCST90314535 | 2.75 |
| 1677 | Fracture at wrist and hand level | FING00000551 | 2.75 |
| 1678 | Mononeuropathies of upper limb | Nerve, nerve root and plexus disorders | UKBB00000481 | 2.75 |
| 1679 | CD40LG/SERPINE1 ratio | GCST90313826 | 2.75 |
| 1680 | NAAA/SMPD1 ratio | GCST90315510 | 2.75 |
| 1681 | VPS4B levels | GCST90471047 | 2.74 |
| 1682 | SSH3 levels | GCST90470749 | 2.74 |
| 1683 | COMP/THBS4 ratio | GCST90314193 | 2.74 |
| 1684 | BCAM/CDH5 ratio | GCST90313469 | 2.74 |
| 1685 | NCR3 levels | GCST90088179 | 2.74 |
| 1686 | ATXN2L levels | GCST90468402 | 2.73 |
| 1687 | Diastolic blood pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000174 | 2.73 |
| 1688 | EIF4E levels | GCST90469096 | 2.73 |
| 1689 | IRF2 levels | GCST90241566 | 2.73 |
| 1690 | QC tfMRI-to-T1 linear alignment discrepancy | GCST90006354 | 2.73 |
| 1691 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T23 | ECGA000023 | 2.73 |
| 1692 | Epstein-Barr virus EA-D antibody levels | GCST90006898 | 2.72 |
| 1693 | Ascending aorta diameter | GCST90267390 | 2.72 |
| 1694 | aparc-pial lh area pericalcarine | GCST90003161 | 2.72 |
| 1695 | Shoulder width to body height ratio | GCST90270261 | 2.72 |
| 1696 | WIF1 levels | GCST90471078 | 2.72 |
| 1697 | BA-exvivo rh thickness BA3b | GCST90003530 | 2.72 |
| 1698 | aparc-Desikan rh thickness cuneus | GCST90003483 | 2.72 |
| 1699 | Medication use (antiglaucoma preparations and miotics) | GCST90018782 | 2.72 |
| 1700 | SPTLC1 levels | GCST90427130 | 2.71 |
| 1701 | ORM1 levels | GCST90470129 | 2.71 |
| 1702 | Diastolic blood pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000179 | 2.71 |
| 1703 | APRT/NSFL1C ratio | GCST90313337 | 2.71 |
| 1704 | GPHA2 levels | GCST90469389 | 2.71 |
| 1705 | F3 levels | GCST90469170 | 2.71 |
| 1706 | PLA2G4A/SNAP29 ratio | GCST90315669 | 2.71 |
| 1707 | Benign neoplasm: Choroid | FING00000170 | 2.71 |
| 1708 | SCLY/SORD ratio | GCST90315816 | 2.71 |
| 1709 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T51 | ECGU000051 | 2.71 |
| 1710 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 110) | GCST90320929 | 2.71 |
| 1711 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T18 | ECGU000018 | 2.71 |
| 1712 | RND3 levels | GCST90618066 | 2.71 |
| 1713 | EPS8L2 levels | GCST90469138 | 2.70 |
| 1714 | Colorectal cancer, excluding all cancers (controls excluding all cancers) | FING00000317 | 2.70 |
| 1715 | Prescriptions - thiazide diuretic|diuretic | UKBB00000704 | 2.70 |
| 1716 | Varicose veins | circulatory system | UKBB00000893 | 2.70 |
| 1717 | DNER levels | GCST90274785 | 2.70 |
| 1718 | Left-hemisphere dorsal attention network to left-hemisphere default mode network white-matter structural connectivity | GCST90302693 | 2.70 |
| 1719 | ERN1 levels | GCST90469148 | 2.70 |
| 1720 | DTI TBSS FA Superior longitudinal fasciculus L | GCST90384421 | 2.70 |
| 1721 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T31 | ECGU000031 | 2.70 |
| 1722 | Right-hemisphere control network to putamen white-matter structural connectivity | GCST90302838 | 2.70 |
| 1723 | DTI TBSS L1 Fornix | GCST90384433 | 2.70 |
| 1724 | PPT1 levels | GCST90427718 | 2.69 |
| 1725 | Diastolic blood pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000175 | 2.69 |
| 1726 | Triacylglycerol_50:3_[M+NH4]1+ levels | GCST90060468 | 2.69 |
| 1727 | IDP dMRI ProbtrackX L1 ilf l | GCST90004260 | 2.69 |
| 1728 | LONP1 levels | GCST90469785 | 2.69 |
| 1729 | IDP dMRI TBSS MO Superior corona radiata R | GCST90003976 | 2.69 |
| 1730 | Polyunsaturated fatty acids to total fatty acids percentage | GCST90502179 | 2.69 |
| 1731 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 102) | GCST90320921 | 2.69 |
| 1732 | Varicose veins | FING00001416 | 2.69 |
| 1733 | Hammer toe (acquired) (PheCode 735.21) | GCST90476250 | 2.69 |
| 1734 | FCRLB levels | GCST90469210 | 2.69 |
| 1735 | DLL4 levels | GCST90469005 | 2.68 |
| 1736 | Modified Stumvoll Insulin Sensitivity Index (adjusted for BMI) | GCST90267573 | 2.68 |
| 1737 | IDP dMRI ProbtrackX MD ptr l | GCST90004238 | 2.68 |
| 1738 | Systolic blood pressure | GCST90025968 | 2.67 |
| 1739 | Leucine levels | GCST90243405 | 2.67 |
| 1740 | HMCN2 levels | GCST90469461 | 2.67 |
| 1741 | Phosphatidylcholine diacyl C38:3 levels | GCST90240045 | 2.67 |
| 1742 | Tyrosine levels | GCST90243425 | 2.67 |
| 1743 | GLRX5 levels | GCST90469361 | 2.66 |
| 1744 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T64 | ECGU000064 | 2.66 |
| 1745 | Osteoarthrosis | musculoskeletal | UKBB00000596 | 2.66 |
| 1746 | HYOU1/THBD ratio | GCST90315106 | 2.66 |
| 1747 | ASGR1 levels | GCST90468375 | 2.66 |
| 1748 | Prescriptions - bendroflumethiazide | thiazide diuretic,diuretic | UKBB00000667 | 2.66 |
| 1749 | Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers) | FING00000041 | 2.65 |
| 1750 | AHNAK2 levels | GCST90468260 | 2.65 |
| 1751 | Pregnenetriol disulfate levels | GCST90200238 | 2.65 |
| 1752 | Left ventricle sphericity index | GCST90268402 | 2.65 |
| 1753 | IDP dMRI TBSS ISOVF Posterior corona radiata L | GCST90004504 | 2.65 |
| 1754 | Systolic blood pressure (BMI adjusted) | GCST90335163 | 2.65 |
| 1755 | rfMRI connectivity (ICA100 edge 383) | GCST90005236 | 2.64 |
| 1756 | Dry age-related macular degeneration (includes geographic atrophy) | FING00000480 | 2.64 |
| 1757 | GORASP2 levels | GCST90469378 | 2.64 |
| 1758 | SFRP4 levels | GCST90470611 | 2.64 |
| 1759 | BA-exvivo rh volume BA6 | GCST90002855 | 2.64 |
| 1760 | IGFBP6/PTGDS ratio | GCST90315137 | 2.64 |
| 1761 | Retinal vascular disorders | FING00001262 | 2.64 |
| 1762 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T423 | ECGA000423 | 2.64 |
| 1763 | Phospholipids to total lipids in large VLDL percentage (UKB data field 23589) | GCST90269686 | 2.63 |
| 1764 | Knee osteoarthritis | GCST007090 | 2.63 |
| 1765 | IDP dMRI ProbtrackX FA unc l | GCST90003950 | 2.63 |
| 1766 | FABP4 levels | GCST90469176 | 2.63 |
| 1767 | Phospholipids in large VLDL | GCST90498247 | 2.63 |
| 1768 | DIABLO/VSIR ratio | GCST90314470 | 2.63 |
| 1769 | GGH/INHBC ratio | GCST90314928 | 2.62 |
| 1770 | aparc-a2009s rh thickness Pole-occipital | GCST90003718 | 2.62 |
| 1771 | DTI TBSS MD Tapetum L | GCST90384619 | 2.62 |
| 1772 | Polyunsaturated fatty acids to total fatty acids percentage (UKB data field 23453) | GCST90269550 | 2.62 |
| 1773 | IDP dMRI TBSS MD Anterior limb of internal capsule L | GCST90004044 | 2.62 |
| 1774 | CDH5/PCDH17 ratio | GCST90313958 | 2.62 |
| 1775 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T371 | ECGU000371 | 2.62 |
| 1776 | aparc-pial lh area caudalmiddlefrontal | GCST90003144 | 2.62 |
| 1777 | aparc-Desikan rh area parsopercularis | GCST90003124 | 2.61 |
| 1778 | ANKRD54 levels | GCST90468311 | 2.61 |
| 1779 | X-21471 levels | GCST90200586 | 2.61 |
| 1780 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T229 | ECGA000229 | 2.61 |
| 1781 | Endometriosis | FING00000497 | 2.61 |
| 1782 | UBE2L6 levels | GCST90471001 | 2.60 |
| 1783 | T1 FreeSurfer DK lh lingual thickness | GCST90385634 | 2.60 |
| 1784 | BLVRB/HAGH ratio | GCST90313524 | 2.59 |
| 1785 | CD27/FCRL5 ratio | GCST90313772 | 2.59 |
| 1786 | aparc-Desikan rh thickness GlobalMeanThickness | GCST90003479 | 2.59 |
| 1787 | GLB1/IMPA1 ratio | GCST90314932 | 2.59 |
| 1788 | aparc-a2009s rh area S-collat-transv-ant | GCST90003420 | 2.59 |
| 1789 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T22 | ECGA000022 | 2.59 |
| 1790 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T50 | ECGU000050 | 2.59 |
| 1791 | SCARA5/SCARF2 ratio | GCST90315808 | 2.59 |
| 1792 | Liver volume | GCST90566818 | 2.58 |
| 1793 | Nonalcoholic fatty liver disease | GCST90091033 | 2.58 |
| 1794 | wg rh intensity-contrast superiortemporal | GCST90003856 | 2.58 |
| 1795 | RSPO3 levels | GCST90470504 | 2.58 |
| 1796 | IDP dMRI ProbtrackX ISOVF ilf l | GCST90004539 | 2.58 |
| 1797 | RAPGEF2 levels | GCST90470426 | 2.58 |
| 1798 | NUB1 levels | GCST90470099 | 2.57 |
| 1799 | TGFBR3 levels | GCST90470848 | 2.57 |
| 1800 | Falls/tendency to fall | FING00000530 | 2.57 |
| 1801 | Triacylglycerol (54:0) [NL-18:0] levels | GCST90025173 | 2.57 |
| 1802 | CD300E/CXCL10 ratio | GCST90313796 | 2.57 |
| 1803 | Volume of left lateral nucleus | GCST90474970 | 2.57 |
| 1804 | EFNA1 levels | GCST90469080 | 2.57 |
| 1805 | RBPMS2 levels | GCST90470441 | 2.56 |
| 1806 | DCTN6 levels | GCST90468960 | 2.56 |
| 1807 | Diastolic blood pressure (BMI adjusted) | GCST90335165 | 2.56 |
| 1808 | MYOC levels | GCST90469983 | 2.55 |
| 1809 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T15 | ECGU000015 | 2.55 |
| 1810 | Trigger finger | FING00001376 | 2.55 |
| 1811 | IDP T1 FAST ROIs L cerebellum I-IV | GCST90002562 | 2.54 |
| 1812 | Breast cancer | GCST90018579 | 2.54 |
| 1813 | ADGRE5/GAS6 ratio | GCST90313179 | 2.54 |
| 1814 | ITGB5 levels | GCST90469645 | 2.54 |
| 1815 | N-acetylmethionine levels | GCST90200289 | 2.54 |
| 1816 | Height (weighted GWA) | GCST90267285 | 2.54 |
| 1817 | ACVRL1/TNFRSF9 ratio | GCST90313160 | 2.53 |
| 1818 | LDLRAP1 levels | GCST90469749 | 2.53 |
| 1819 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 101) | GCST90320920 | 2.53 |
| 1820 | CALCA levels | GCST90468528 | 2.53 |
| 1821 | THBS2 levels | GCST90470854 | 2.53 |
| 1822 | GLA levels | GCST90469354 | 2.53 |
| 1823 | PTRHD1 levels | GCST90470389 | 2.53 |
| 1824 | Acne (PheCode 706.1) | GCST90476211 | 2.53 |
| 1825 | Right-hemisphere dorsal attention network to hippocampus white-matter structural connectivity | GCST90302810 | 2.53 |
| 1826 | Mean arterial pressure | GCST90018743 | 2.53 |
| 1827 | Lactate levels | GCST90092882 | 2.52 |
| 1828 | Cryptic phenotype that captures autosomal dominant polycystic kidney disease severity | GCST90101829 | 2.52 |
| 1829 | LAG3/VCAM1 ratio | GCST90315270 | 2.52 |
| 1830 | IDP dMRI TBSS MD Uncinate fasciculus R | GCST90004071 | 2.52 |
| 1831 | Sciatica+with lumbago | FING00001279 | 2.52 |
| 1832 | RUVBL1 levels | GCST90470509 | 2.52 |
| 1833 | CD99L2 levels | GCST90468657 | 2.52 |
| 1834 | ThalamNuclei rh volume VAmc | GCST90002747 | 2.51 |
| 1835 | Kynurenine levels | GCST90243477 | 2.51 |
| 1836 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T225 | ECGU000225 | 2.51 |
| 1837 | Liver proton density fat fraction | GCST90267352 | 2.51 |
| 1838 | T1 FreeSurfer a2009s rh G&S subcentral volume | GCST90385041 | 2.51 |
| 1839 | Late-onset myasthenia gravis | GCST90432158 | 2.51 |
| 1840 | IDP dMRI TBSS L1 Cingulum hippocampus R | GCST90004111 | 2.51 |
| 1841 | AHCY/FABP5 ratio | GCST90313208 | 2.50 |
| 1842 | CA2/HMBS ratio | GCST90313579 | 2.50 |
| 1843 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T35 | ECGA000035 | 2.50 |
| 1844 | MTSS1 levels | GCST90469960 | 2.50 |
| 1845 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T303 | ECGU000303 | 2.50 |
| 1846 | MECR levels | GCST90469879 | 2.50 |
| 1847 | CD69/PPP1R2 ratio | GCST90313882 | 2.50 |
| 1848 | PLG levels | GCST90470257 | 2.49 |
| 1849 | SORD levels | GCST90470709 | 2.49 |
| 1850 | MSR1 levels | GCST90469950 | 2.49 |
| 1851 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T396 | ECGA000396 | 2.49 |
| 1852 | F7/VASN ratio | GCST90314745 | 2.49 |
| 1853 | GERD | digestive | UKBB00000283 | 2.49 |
| 1854 | TMPRSS11D levels | GCST90470891 | 2.49 |
| 1855 | Triacylglycerol_56:6_[M+NH4]1+ levels | GCST90060553 | 2.48 |
| 1856 | HippSubfield rh volume CA3-head | GCST90002707 | 2.48 |
| 1857 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 125) | GCST90320944 | 2.48 |
| 1858 | Colitis, primary sclerosing, strict definition | FING00000313 | 2.48 |
| 1859 | Glaucoma, exfoliation | FING00000580 | 2.48 |
| 1860 | LACTB2 levels | GCST90469726 | 2.48 |
| 1861 | Main speciality of consultant (recoded) - Cardiology | Summary Administration | UKBB00000414 | 2.48 |
| 1862 | PHYKPL levels | GCST90470228 | 2.48 |
| 1863 | CES1 levels | GCST90468718 | 2.48 |
| 1864 | Low hand grip strength (60 years and older) (EWGSOP) | GCST90007528 | 2.48 |
| 1865 | Pain and other conditions associated with female genital organs and menstrual cycle | FING00001136 | 2.48 |
| 1866 | IDP dMRI ProbtrackX L2 cst r | GCST90004282 | 2.48 |
| 1867 | NSFL1C/RILP ratio | GCST90315560 | 2.48 |
| 1868 | RGCC levels | GCST90470461 | 2.47 |
| 1869 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T372 | ECGU000372 | 2.47 |
| 1870 | aparc-pial lh area cuneus | GCST90003145 | 2.47 |
| 1871 | ANGPTL4 levels | GCST90468305 | 2.47 |
| 1872 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 87) | GCST90320906 | 2.47 |
| 1873 | ADAMTSL4 levels | GCST90468229 | 2.47 |
| 1874 | Varicose veins (PheCode 454) | GCST90476012 | 2.47 |
| 1875 | Parental longevity (father's attained age) | GCST006701 | 2.47 |
| 1876 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 42) | GCST90320861 | 2.46 |
| 1877 | Degree of unsaturation | GCST90502231 | 2.46 |
| 1878 | Keratitis | FING00000708 | 2.46 |
| 1879 | wg lh intensity-contrast temporalpole | GCST90003824 | 2.46 |
| 1880 | NRGN levels | GCST90470083 | 2.46 |
| 1881 | ICAM5 levels | GCST90469502 | 2.46 |
| 1882 | wg lh intensity-contrast inferiorparietal | GCST90003799 | 2.46 |
| 1883 | FGF19 levels | GCST90469220 | 2.46 |
| 1884 | ITGA2 levels | GCST90469634 | 2.46 |
| 1885 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 44) | GCST90320607 | 2.45 |
| 1886 | Cellulitis and abscess of leg, except foot (PheCode 681.5) | GCST90476166 | 2.45 |
| 1887 | NT5C3A levels | GCST90470091 | 2.45 |
| 1888 | IGF1 levels | UKBB00000337 | 2.45 |
| 1889 | CELSR2 levels | GCST90468703 | 2.45 |
| 1890 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T104 | ECGU000104 | 2.44 |
| 1891 | X-26109 levels | GCST90200671 | 2.44 |
| 1892 | BIRC2/CD40LG ratio | GCST90313517 | 2.44 |
| 1893 | IDP dMRI ProbtrackX L1 cgh l | GCST90004252 | 2.44 |
| 1894 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T17 | ECGA000017 | 2.44 |
| 1895 | COL6A3/SPON2 ratio | GCST90314179 | 2.44 |
| 1896 | aparc-pial rh area cuneus | GCST90003178 | 2.44 |
| 1897 | AXIN1/IKBKG ratio | GCST90313409 | 2.44 |
| 1898 | SHMT1 levels | GCST90470627 | 2.44 |
| 1899 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T19 | ECGA000019 | 2.43 |
| 1900 | Left-hemisphere control network to accumbens white-matter structural connectivity | GCST90302758 | 2.43 |
| 1901 | MANSC1/PODXL ratio | GCST90315372 | 2.43 |
| 1902 | Forced expiratory volume in 1-second (FEV1) | Spirometry | UKBB00000251 | 2.43 |
| 1903 | MTDH levels | GCST90469954 | 2.43 |
| 1904 | DTI autoptx L2 atr l tract | GCST90385168 | 2.43 |
| 1905 | Chronic hepatitis B infection | GCST90018584 | 2.43 |
| 1906 | ERP29 levels | GCST90088843 | 2.43 |
| 1907 | ALB levels | GCST90497108 | 2.43 |
| 1908 | HSD11B1/SMPD1 ratio | GCST90315082 | 2.42 |
| 1909 | BCAM levels | GCST90468425 | 2.42 |
| 1910 | Barrett's esophagus | GCST90000515 | 2.42 |
| 1911 | Spinal stenosis | FING00001322 | 2.42 |
| 1912 | MEGF9/MET ratio | GCST90315418 | 2.42 |
| 1913 | IDP dMRI TBSS ICVF Cingulum hippocampus L | GCST90004364 | 2.41 |
| 1914 | MOG/PTPRN2 ratio | GCST90315475 | 2.41 |
| 1915 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T106 | ECGU000106 | 2.41 |
| 1916 | CHAC2 levels | GCST90468736 | 2.41 |
| 1917 | ANG/F9 ratio | GCST90313259 | 2.40 |
| 1918 | Disorders of ocular muscles, binocular movement, accommodation and refraction | FING00000446 | 2.40 |
| 1919 | FLRT2 levels | GCST90469248 | 2.40 |
| 1920 | CR2 levels | GCST90468852 | 2.40 |
| 1921 | Left-hemisphere control network to putamen white-matter structural connectivity | GCST90302754 | 2.40 |
| 1922 | Peak expiratory flow (UKB data field 3064) | GCST90468176 | 2.40 |
| 1923 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 7) | GCST90320570 | 2.39 |
| 1924 | aparc-DKTatlas lh area pericalcarine | GCST90003253 | 2.39 |
| 1925 | CDH5/NOTCH1 ratio | GCST90313957 | 2.39 |
| 1926 | Treatment/medication code - lansoprazole | Medications | UKBB00000848 | 2.39 |
| 1927 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T17 | ECGU000017 | 2.39 |
| 1928 | ANXA11 levels | GCST90468315 | 2.39 |
| 1929 | MIA/NBL1 ratio | GCST90315445 | 2.38 |
| 1930 | CA5A/KRT18 ratio | GCST90313592 | 2.38 |
| 1931 | PRKAR1A/SNAP23 ratio | GCST90315728 | 2.38 |
| 1932 | PPIB levels | GCST90470291 | 2.37 |
| 1933 | UNC5D levels | GCST90471010 | 2.37 |
| 1934 | Vertical cup-disc ratio | GCST004075 | 2.37 |
| 1935 | MARS1 levels | GCST90469862 | 2.37 |
| 1936 | IDP dMRI TBSS L2 Superior fronto-occipital fasciculus L | GCST90004166 | 2.37 |
| 1937 | Alanine transaminase (ALT, mean, inv-norm transformed) | GCST90475112 | 2.37 |
| 1938 | Spherical power (right) | Autorefraction | UKBB00000791 | 2.36 |
| 1939 | PDGFC/TFPI ratio | GCST90315636 | 2.36 |
| 1940 | Volume of right paralaminar nucleus | GCST90474928 | 2.36 |
| 1941 | PRAP1 levels | GCST90470312 | 2.36 |
| 1942 | ENAH levels | GCST90469106 | 2.36 |
| 1943 | Diastolic blood pressure (MTAG) | GCST90449057 | 2.36 |
| 1944 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T24 | ECGA000024 | 2.36 |
| 1945 | Gonarthrosis [arthrosis of knee] | Arthrosis | UKBB00000290 | 2.36 |
| 1946 | DTI autoptx FA unc r tract | GCST90385138 | 2.36 |
| 1947 | CLEC1A/TNFRSF1A ratio | GCST90314085 | 2.36 |
| 1948 | diastolic blood pressure (DBP, maximum, inv-normal transformed) | GCST90475252 | 2.36 |
| 1949 | STAT2 levels | GCST90470758 | 2.36 |
| 1950 | AKT2 levels | GCST90468277 | 2.35 |
| 1951 | IDP dMRI TBSS L2 Posterior thalamic radiation L | GCST90004152 | 2.35 |
| 1952 | Redundant prepuce, phimosis and paraphimosis | FING00001246 | 2.35 |
| 1953 | TWF2 levels | GCST90470987 | 2.35 |
| 1954 | CRIP2 levels | GCST90468864 | 2.35 |
| 1955 | GFRA1/SPON2 ratio | GCST90314923 | 2.34 |
| 1956 | Testosterone levels (UKB data field 30850) | GCST90468103 | 2.34 |
| 1957 | FABP2/RBP2 ratio | GCST90314757 | 2.34 |
| 1958 | IDP dMRI ProbtrackX ICVF cgh r | GCST90004382 | 2.34 |
| 1959 | COL15A1 levels | GCST90468811 | 2.34 |
| 1960 | GET3 levels | GCST90469324 | 2.34 |
| 1961 | Myocardial fractal dimension (slice 8) | GCST90000294 | 2.34 |
| 1962 | SMAD2 levels | GCST90470676 | 2.34 |
| 1963 | SNX5 levels | GCST90470702 | 2.34 |
| 1964 | Aspartate aminotransferase | Blood biochemistry | UKBB00000052 | 2.34 |
| 1965 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T184 | ECGU000184 | 2.34 |
| 1966 | DKK4/REG1A ratio | GCST90314489 | 2.33 |
| 1967 | Other diseases of the digestive system | FING00001010 | 2.33 |
| 1968 | Triacylglycerol_51:3_[M+NH4]1+ levels | GCST90060494 | 2.33 |
| 1969 | IDP dMRI TBSS MD Posterior thalamic radiation R | GCST90004055 | 2.33 |
| 1970 | Diastolic blood pressure | GCST90301700 | 2.32 |
| 1971 | FURIN/PLA2G15 ratio | GCST90314887 | 2.32 |
| 1972 | STXBP1 levels | GCST90470777 | 2.32 |
| 1973 | Omega-6 fatty acids to total fatty acids percentage | GCST90502127 | 2.32 |
| 1974 | SNX9/STIP1 ratio | GCST90315864 | 2.32 |
| 1975 | SLC27A4/TDRKH ratio | GCST90315851 | 2.32 |
| 1976 | Left-hemisphere somatomotor network to amygdala white-matter structural connectivity | GCST90302687 | 2.31 |
| 1977 | Pain type(s) experienced in last month - Back pain | Pain | UKBB00000626 | 2.31 |
| 1978 | IDP dMRI ProbtrackX FA ifo l | GCST90003937 | 2.31 |
| 1979 | ACP5 levels | GCST90468203 | 2.31 |
| 1980 | Ischemic stroke | GCST90018644 | 2.31 |
| 1981 | BLMH/PEAR1 ratio | GCST90313519 | 2.31 |
| 1982 | REG1A/REG4 ratio | GCST90315762 | 2.31 |
| 1983 | CNPY4 levels | GCST90468800 | 2.31 |
| 1984 | aseg global intensity 4th-Ventricle | GCST90003752 | 2.31 |
| 1985 | IDP dMRI TBSS FA Sagittal stratum L | GCST90003908 | 2.30 |
| 1986 | CCN3 levels | GCST90242492 | 2.30 |
| 1987 | PDAP1 levels | GCST90470179 | 2.30 |
| 1988 | MDH1 levels | GCST90469876 | 2.30 |
| 1989 | GPR37 levels | GCST90469397 | 2.30 |
| 1990 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T300 | ECGU000300 | 2.30 |
| 1991 | RBP2 levels | GCST90470438 | 2.30 |
| 1992 | PCBP2 levels | GCST90470167 | 2.30 |
| 1993 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T373 | ECGU000373 | 2.29 |
| 1994 | GRHPR levels | GCST90469400 | 2.29 |
| 1995 | MPO levels | GCST90469937 | 2.29 |
| 1996 | SNAP29/TJAP1 ratio | GCST90315861 | 2.29 |
| 1997 | Pregnenediol disulfate (C21H34O8S2) levels | GCST90199840 | 2.29 |
| 1998 | Milk type used: Soy milk vs never have milk (UKB data field 1418) | GCST90132943 | 2.28 |
| 1999 | Hypertension | FING00000637 | 2.28 |
| 2000 | SELE levels | GCST90470566 | 2.28 |